$120,000 of NOVO NORDISK INC. lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Guidance regarding pharmaceutical regulations."
You can find more data on corporate lobbying on Quiver Quantitative.
NVO Congressional Stock Trading
Members of Congress have traded $NVO stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $NVO stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
NVO Hedge Fund Activity
We have seen 575 institutional investors add shares of NVO stock to their portfolio, and 762 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL INTERNATIONAL INVESTORS removed 6,502,318 shares (-36.7%) from their portfolio in Q4 2025, for an estimated $330,837,939
- PRICE T ROWE ASSOCIATES INC /MD/ added 4,836,285 shares (+99.7%) to their portfolio in Q4 2025, for an estimated $246,070,180
- VOLORIDGE INVESTMENT MANAGEMENT, LLC added 4,302,126 shares (+851.6%) to their portfolio in Q4 2025, for an estimated $218,892,170
- CITADEL ADVISORS LLC added 4,278,889 shares (+136.6%) to their portfolio in Q4 2025, for an estimated $217,709,872
- FMR LLC removed 4,058,066 shares (-28.8%) from their portfolio in Q4 2025, for an estimated $206,474,398
- FAYEZ SAROFIM & CO removed 3,118,838 shares (-42.4%) from their portfolio in Q4 2025, for an estimated $158,686,477
- DAVENPORT & CO LLC removed 2,122,035 shares (-96.2%) from their portfolio in Q1 2026, for an estimated $76,085,564
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
NVO Analyst Ratings
Wall Street analysts have issued reports on $NVO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Buy" rating on 11/28/2025
- Jefferies issued a "Underperform" rating on 10/27/2025
To track analyst ratings and price targets for NVO, check out Quiver Quantitative's $NVO forecast page.
NVO Price Targets
Multiple analysts have issued price targets for $NVO recently. We have seen 3 analysts offer price targets for $NVO in the last 6 months, with a median target of $46.0.
Here are some recent targets:
- James Quigley from Goldman Sachs set a target price of $41.0 on 03/02/2026
- An analyst from CICC set a target price of $73.5 on 01/09/2026
- Evan David Seigerman from BMO Capital set a target price of $46.0 on 11/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
